Bovilis Nasalgen-C

A vaccine for the active immunisation of cattle from the day of birth onwards to reduce clinical signs of upper respiratory tract disease and nasal viral shedding from infection with bovine coronavirus

Product Information for Veterinary Healthcare Professionals and Professional Keepers of Animals

Qualitative and Quantitative Composition

Each dose (2 ml) of reconstituted vaccine contains:

Active substance:

Live attenuated bovine coronavirus, strain CA25: 5.4 – 7.8 log10 TCID50*

*Tissue culture infectious dose 50%

Indications for use for each target species

For the active immunisation of cattle from the day of birth onwards to reduce clinical signs of upper respiratory tract disease and nasal viral shedding from infection with bovine coronavirus.

Onset of immunity: 5 days.

Duration of immunity: 12 weeks.

For uses, dosage, contra-indications and warnings please consult the Summary of Product Characteristics (SPC) or your veterinary supplier. Further information is available on request. Use medicines responsibly. 

Legal category 
POM-V

Packaging Quantities 

Cardboard box with:

1 dose of lyophilisate + 2 ml solvent, 5 doses of lyophilisate + 10 ml solvent, 10 doses of lyophilisate + 20 ml, solvent, 5 x 1 dose of lyophilisate + 5 x 2 ml solvent, 5 x 5 doses of lyophilisate + 5 x 10 ml solvent, 5 x 10 doses of lyophilisate + 5 x 20 ml solvent, Cardboard box with 20 doses of lyophilisate + cardboard box with 40 ml solvent, Cardboard box with 50 doses of lyophilisate + cardboard box with 100 ml solvent.

Not all pack sizes may be marketed.

Summary of Product Characteristics (SPC)

For Summary of Product Characteristics, first click on this link. Then type in Bovilis Nasalgen-C in Product name field. Click on Run search. Subsequently click on View SPC on line listing opposite Bovilis Nasalgen-C.